|
DARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.82290000000562E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.481800E-03 |
| Normal-vs-Stage2 |
1.975110E-03 |
| Normal-vs-Stage3 |
8.590100E-04 |
| Normal-vs-Stage4 |
5.882500E-03 |
| Stage1-vs-Stage2 |
4.426000E-02 |
| Stage1-vs-Stage3 |
3.303600E-02 |
| Stage1-vs-Stage4 |
1.782320E-02 |
| Stage2-vs-Stage3 |
9.109600E-01 |
| Stage2-vs-Stage4 |
6.219800E-02 |
| Stage3-vs-Stage4 |
4.056200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.50240000000146E-05 |
| Normal-vs-AfricanAmerican |
2.002800E-03 |
| Normal-vs-Asian |
3.044200E-01 |
| Caucasian-vs-AfricanAmerican |
6.560400E-01 |
| Caucasian-vs-Asian |
8.193400E-01 |
| AfricanAmerican-vs-Asian |
9.487600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.586300E-04 |
| Normal-vs-Female |
1.47579999998371E-06 |
| Male-vs-Female |
1.383790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.388010E-02 |
| Normal-vs-Extreme_Weight |
4.784100E-02 |
| Normal-vs-Obese |
1.990920E-04 |
| Normal-vs-Extreme_Obese |
2.101800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.267000E-01 |
| Normal_Weight-vs-Obese |
3.314600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.331400E-01 |
| Extreme_Weight-vs-Obese |
1.856190E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.034800E-01 |
| Obese-vs-Extreme_Obese |
6.365200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.463900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.39809999968976E-07 |
| Normal-vs-Age(61-80Yrs) |
2.366000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.091400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.522100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.040200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.468400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.643500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.569830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.033100E-04 |
| Normal-VS-Type2 PRCC |
8.920600E-03 |
| Normal-VS-KIRP CIMP |
6.616200E-04 |
| Normal-VS-Unclassified PRCC |
9.160600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.558000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.63980000081432E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
7.860300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.231200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.202000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.830800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.479600E-02 |
| Normal-vs-N1 |
1.352700E-04 |
| Normal-vs-N2 |
9.596300E-02 |
| N0-vs-N1 |
1.767980E-02 |
| N0-vs-N2 |
3.323800E-01 |
| N1-vs-N2 |
8.456200E-01 |
|
|
